A Study to Evaluate the Effects of KP-001 on the QT/QTc Intervals in Healthy Adults

Clinical trial NCT06649942 · COMPLETED

Trial details

NCT number: NCT06649942
Sponsor: Kaken Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers - Male and Female

Start date: 2024-10-01
Primary completion: 2025-03-24
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.